ArticleDiagnostics (Basel, Switzerland)2023

Validation Study of Novel Point-of-Care Tests for Infliximab, Adalimumab and C-Reactive Protein in Capillary Blood and Calprotectin in Faeces in an Ambulatory Inflammatory Bowel Disease Care Setting.

Adriaan Volkers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.